Dorsey & Whitney Trust CO LLC Buys Shares of 1,459 The Clorox Company (NYSE:CLX)

Dorsey & Whitney Trust CO LLC acquired a new position in The Clorox Company (NYSE:CLXFree Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 1,459 shares of the company’s stock, valued at approximately $208,000.

A number of other large investors also recently added to or reduced their stakes in the company. Norges Bank acquired a new stake in Clorox during the 4th quarter worth approximately $128,382,000. Qube Research & Technologies Ltd increased its stake in shares of Clorox by 75.9% during the third quarter. Qube Research & Technologies Ltd now owns 1,130,481 shares of the company’s stock worth $148,161,000 after buying an additional 487,974 shares during the period. International Assets Investment Management LLC raised its holdings in Clorox by 17,658.5% in the fourth quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock valued at $69,078,000 after acquiring an additional 481,725 shares in the last quarter. Acadian Asset Management LLC lifted its stake in Clorox by 39.6% in the third quarter. Acadian Asset Management LLC now owns 1,467,713 shares of the company’s stock worth $192,319,000 after acquiring an additional 415,999 shares during the last quarter. Finally, FMR LLC grew its holdings in Clorox by 17.4% during the 3rd quarter. FMR LLC now owns 2,415,054 shares of the company’s stock worth $316,517,000 after acquiring an additional 357,964 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Trading Down 0.3 %

Shares of CLX stock opened at $131.10 on Tuesday. The Clorox Company has a fifty-two week low of $114.68 and a fifty-two week high of $169.14. The company has a quick ratio of 0.53, a current ratio of 0.90 and a debt-to-equity ratio of 9.73. The business has a fifty day simple moving average of $141.40 and a 200-day simple moving average of $144.75. The stock has a market cap of $16.28 billion, a P/E ratio of 67.93, a P/E/G ratio of 2.03 and a beta of 0.39.

Clorox (NYSE:CLXGet Free Report) last posted its earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.38. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The firm had revenue of $1.81 billion during the quarter, compared to the consensus estimate of $1.87 billion. During the same period last year, the firm posted $1.51 EPS. The firm’s revenue for the quarter was down 5.3% on a year-over-year basis. On average, analysts forecast that The Clorox Company will post 5.83 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on CLX. UBS Group reduced their price objective on shares of Clorox from $164.00 to $159.00 and set a “neutral” rating on the stock in a report on Wednesday, May 1st. Wells Fargo & Company dropped their price objective on Clorox from $140.00 to $135.00 and set an “underweight” rating on the stock in a report on Thursday, May 2nd. DA Davidson restated a “neutral” rating and issued a $162.00 price objective on shares of Clorox in a research note on Wednesday, April 17th. Deutsche Bank Aktiengesellschaft reduced their price target on shares of Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a research report on Wednesday, April 17th. Finally, Morgan Stanley reaffirmed an “equal weight” rating and set a $160.00 price objective on shares of Clorox in a research report on Tuesday, March 26th. Four investment analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $146.43.

Get Our Latest Stock Analysis on CLX

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.